Imeik Technology Development Co (300896) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.032x

Based on the latest financial reports, Imeik Technology Development Co (300896) has a cash flow conversion efficiency ratio of 0.032x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥257.61 Million ≈ $37.70 Million USD) by net assets (CN¥8.16 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Imeik Technology Development Co fund operations to measure how many days the company can operate on defensive assets alone.

Imeik Technology Development Co - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Imeik Technology Development Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Imeik Technology Development Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imeik Technology Development Co ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Tongcheng Travel Holdings Ltd
F:TEM
0.017x
Ming Yang Smart Energy Group Ltd
SHG:601615
-0.049x
Godrej Industries Limited
NSE:GODREJIND
-0.176x
Gitlab Inc
NASDAQ:GTLB
0.044x
JCDECAUX SE ADR 1/2/O.N.
F:DCS0
N/A
Liaoning Port Co Ltd
SHG:601880
0.032x
Glarun Technology Co Ltd
SHG:600562
-0.001x
Just Eat Takeaway
AS:TKWY
0.039x

Annual Cash Flow Conversion Efficiency for Imeik Technology Development Co (2014–2025)

The table below shows the annual cash flow conversion efficiency of Imeik Technology Development Co from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Imeik Technology Development Co worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.16 Billion
≈ $1.19 Billion
CN¥1.39 Billion
≈ $202.93 Million
0.170x -29.93%
2024-12-31 CN¥7.95 Billion
≈ $1.16 Billion
CN¥1.93 Billion
≈ $282.01 Million
0.242x -19.55%
2023-12-31 CN¥6.49 Billion
≈ $948.97 Million
CN¥1.95 Billion
≈ $285.94 Million
0.301x +50.06%
2022-12-31 CN¥5.95 Billion
≈ $870.05 Million
CN¥1.19 Billion
≈ $174.71 Million
0.201x +7.13%
2021-12-31 CN¥5.03 Billion
≈ $736.01 Million
CN¥942.78 Million
≈ $137.96 Million
0.187x +99.53%
2020-12-31 CN¥4.53 Billion
≈ $663.06 Million
CN¥425.68 Million
≈ $62.29 Million
0.094x -79.90%
2019-12-31 CN¥662.70 Million
≈ $96.97 Million
CN¥309.72 Million
≈ $45.32 Million
0.467x +39.60%
2018-12-31 CN¥404.74 Million
≈ $59.23 Million
CN¥135.50 Million
≈ $19.83 Million
0.335x +30.60%
2017-12-31 CN¥328.31 Million
≈ $48.04 Million
CN¥84.16 Million
≈ $12.32 Million
0.256x +23.74%
2016-12-31 CN¥265.49 Million
≈ $38.85 Million
CN¥55.00 Million
≈ $8.05 Million
0.207x -35.02%
2015-12-31 CN¥151.66 Million
≈ $22.19 Million
CN¥48.35 Million
≈ $7.07 Million
0.319x +0.43%
2014-12-31 CN¥88.06 Million
≈ $12.89 Million
CN¥27.95 Million
≈ $4.09 Million
0.317x --

About Imeik Technology Development Co

SHE:300896 China Medical Instruments & Supplies
Market Cap
$4.05 Billion
CN¥27.64 Billion CNY
Market Cap Rank
#4171 Global
#683 in China
Share Price
CN¥91.36
Change (1 day)
+0.48%
52-Week Range
CN¥90.92 - CN¥201.00
All Time High
CN¥570.69
About

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate compos… Read more